Science & Technology Current Affairs MCQs

Notes:
Russia announced plans to launch the Venera-D mission to revisit Venus before 2036. Preliminary design work will begin in January 2026 under the new national space programme. The mission is being developed in collaboration with the Lavochkin Association. It will include a lander, a balloon probe, and an orbital spacecraft for comprehensive study of Venus. The design phase will take two years to complete. The launch is expected between 2034 and 2036, with the exact date decided after the design phase.

Notes:
The World Health Organization (WHO) recently announced that Nepal has eliminated rubella as a public health problem. Rubella, also called German measles or three-day measles, is a contagious viral infection known for its red rash. It is caused by the Rubella virus, a single-stranded RNA virus, different from the measles virus. Rubella spreads through coughing, sneezing, contaminated surfaces, and from mother to fetus during pregnancy. This can lead to fetal death or Congenital Rubella Syndrome (CRS), causing hearing loss, eye and heart defects, autism, diabetes mellitus, and thyroid problems.

Notes:
Researchers at the Institute of Nano Science and Technology (INST), Mohali, are developing a nanotechnology-based tool for early detection of Parkinson’s Disease (PD). Parkinson’s Disease (PD) is a rapidly growing neurological disorder in India, often diagnosed after significant neurodegeneration. The team focused on α-synuclein, a protein that changes from harmless to toxic forms, damaging brain cells. They created gold nanoclusters (AuNCs), ultrasmall particles coated with amino acids to selectively bind normal or toxic protein forms. The tool enables early-stage detection, improving treatment, quality of life, and reducing healthcare costs.

Notes:
CEREBO is a hand-held, portable, non-invasive brain injury diagnostic tool developed by Indian Council of Medical Research (ICMR), Medical Device & Diagnostics Mission Secretariat (MDMS), AIIMS Bhopal, NIMHANS Bengaluru, and Bioscan Research. It is designed for Traumatic Brain Injuries (TBIs) and detects intracranial bleeding and edema within a minute. The device is safe for infants and pregnant women and usable by paramedics and unskilled personnel. CEREBO provides colour-coded, radiation-free, cost-effective results where CT or MRI scans are inaccessible or delayed. It can be deployed in ambulances, trauma centres, rural clinics, and disaster response units.

Notes:
India unveiled its first fully indigenous 32-bit microprocessor, Vikram 3201, at Semicon India 2025. It is designed by Vikram Sarabhai Space Center (VSSC) and fabricated by Indian Space Research Organisation’s (ISRO) Semiconductor Laboratory (SCL), Chandigarh. Vikram 3201 is designed specifically for rockets and satellites, unlike processors in smartphones or laptops. It is an upgrade of Vikram 1601, a 16-bit processor used in ISRO launch vehicles since 2009. The processor manages navigation, control, and mission management in launch vehicles. The launch supports India’s semiconductor self-reliance, with five units under construction under the Design-Linked Incentive scheme.

Notes:
Researchers at S. N. Bose National Centre for Basic Sciences (SNBNCBS) discovered protein p47’s new role as a “mechanical chaperone.” P47 is a cofactor protein known for assisting p97 in protein trafficking, degradation, and membrane fusion. Study revealed p47 boosts mechanical efficiency of protein extraction from endoplasmic reticulum (ER) to cytoplasm. It stabilizes polypeptides under stress, guides them through pores, prevents misfolding, and improves translocation. This is the first single-molecule evidence of autonomous, force-dependent chaperone-like activity by p47. Discovery opens new therapeutic possibilities for diseases linked to protein instability.

Notes:
Cholesterol, a fat-like substance, can control the spin of electrons, a quantum property crucial for next-generation spintronic devices. Spintronics uses electron spin to develop energy-efficient electronics and bioelectronic devices. Scientists from the Institute of Nano Science and Technology (INST), Mohali, under the Department of Science and Technology (DST), developed cholesterol-based nanomaterials for spintronic and quantum applications. Cholesterol’s intrinsic handedness (chirality) and flexibility allow precise control over molecular properties. This innovation could enable energy-efficient memory chips and greener quantum technologies.

Notes:
India has licensed Indian Immunologicals Limited, Techinvention Lifecare Private Limited, Panacea Biotec Limited, Biological E Limited, and Zydus Lifesciences for manufacturing its first indigenous multi-stage malaria vaccine (AdFalciVax). The vaccine was developed by Indian Council of Medical Research (ICMR) and partners. It targets Plasmodium falciparum before it enters the bloodstream to prevent transmission. The vaccine is affordable, stable, scalable, and effective for over 9 months at room temperature.

Notes:
Apollo Hospitals Enterprise Ltd (AHEL) launched Apollo Athenaa, Asia’s first dedicated cancer centre for women, at Defence Colony, New Delhi. The centre was inaugurated by Delhi Chief Minister Rekha Gupta, along with Dr. Prathap C Reddy and Preetha Reddy of Apollo Hospitals Group. GLOBOCAN 2022 data shows 54% of cancers in Indian women are breast and cervical, highlighting urgent need for specialised care. The centre provides services like preventive screenings, advanced diagnostics, surgical oncology, breast oncoplasty, fertility preservation, reconstructive care, onco-psychology, nutrition, physiotherapy, and palliative care.

Notes:
Maulana Azad Medical College (MAMC), Delhi, launched the city’s first Central Tissue Bank for bone grafting in dental surgeries. The facility was inaugurated by Delhi Health Minister Dr Pankaj Kumar Singh. Bone grafting helps reverse jawbone loss and supports dental implants, dentures, and tissue regeneration. The tissue bank provides ready access to high-quality bone and soft tissue grafts, reducing cost and addressing limited availability.